An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  International Journal of Radiation Oncology, Biology, Physics

• Publication date

  2005-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.IJROBP.2005.05.005PMID 16099596
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adjuvant therapy in gastric cancer.

  2005cited by this paper
• Impact of INT-0116 Trial on adjuvant treatment of gastric cancer.

  2004cited by this paper
• Patterns of failure in gastric carcinoma after D2 gastrectomy and chemoradiotherapy: a radiation oncologist's view

  2004cited by this paper
• Is it Time to Change Surgical Strategy for Gastric Cancer in the United States?

  2004cited by this paper
• Clinical overview: adjuvant therapy of gastrointestinal cancer

  2004cited by this paper
• Principles of surgical treatment for curable gastric cancer.

  2003cited by this paper
• The gastric cancer treatment controversy.

  2003cited by this paper
• Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.

  2003cited by this paper
• Postoperative chemoradiotherapy for gastric cancer.

  2003influential reference
• Adjuvant therapy for gastric cancer.

  2003cited by this paper
• Annual Report of the Korea Central Cancer Registry Program 2000: Based on Registered Data from 131 Hospitals.

  2002cited by this paper
• Surgical quality in trials of adjuvant cancer therapy

  2002cited by this paper
• Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroœsophageal junction

  2002influential reference
• Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: The effect of undertreatment

  2002cited by this paper
• Targeting the optimal extent of lymph node dissection for gastric cancer

  2002cited by this paper
• Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.

  2001cited by this paper
• Surgical management of gastric cancer

  2001cited by this paper
• Recurrence following curative resection for gastric carcinoma

  2000cited by this paper
• Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer

  2000cited by this paper
• Extended lymph-node dissection for gastric cancer.

  1999cited by this paper
• Adjuvant therapy for gastric carcinoma patients in the past 15 years

  1999cited by this paper
• Management of Upper Gastrointestinal Cancer

  1999cited by this paper
• Japanese Classification of Gastric Carcinoma – 2nd English Edition –

  1998cited by this paper
• Japanese Classification of Gastric Carcinoma – 2nd English Edition –

  1998cited by this paper
• Patterns of failure following curative resection of gastric carcinoma.

  1990cited by this paper
• Combined 5-fluorouracil and radiation therapy as a surgical adjuvant for poor prognosis gastric carcinoma.

  1984cited by this paper
• Toxicity and response criteria of the Eastern Cooperative Oncology Group

  1982cited by this paper
• Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy.

  1982cited by this paper
• [Adenocarcinoma of the stomach].

  1980cited by this paper

• Classical biomarkers and non-coding RNAs associated with diagnosis and treatment in gastric cancer

  2025cites this paper
• Gastric Carcinoma Patients with Advanced Pathological Lymph Node Stage Benefit from Postoperative Radiotherapy: A Retrospective Analysis

  2025cites this paper
• Preoperative Chemoradiotherapy versus Chemotherapy for Locally Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma: A Phase III Randomized Controlled Trial from China

  2025cites this paper
• Comparative study of the outcomes of robotic versus laparoscopic distal gastrectomy with hand-sewn anastomosis in Billroth-I reconstruction

  2025cites this paper
• ASAP1 protein macromolecule promotes the growth and development of gastric cancer cells and the remodeling of F-actin cytoskeleton: Expression of VEGF and HIF-1 α proteins.

  2025cites this paper
• Efficacy and safety of docetaxel plus S-1-based therapy in gastric cancer: a quantitative evidence synthesis of randomized controlled trials

  2024cites this paper
• Targeting HSP90 with picropodophyllin suppresses gastric cancer tumorigenesis by disrupting the association of HSP90 and AKT

  2023cites this paper
• Comparative outcomes of laparoscopic and robotic approaches to gastrectomy: a National Cancer Database study

  2023cites this paper
• Updated Adjuvant Chemotherapy for Gastric Cancer

  2023cites this paper
• Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2022cites this paper
• α2,3 sialic acid processing enzymes expression in gastric cancer tissues reveals that ST3Gal3 but not Neu3 are associated with Lauren's classification, angiolymphatic invasion and histological grade

  2022cites this paper
• Effect of Adjuvant Chemotherapy/Chemoradiotherapy on Disease-Free Survival in Gastric Cancer

  2022cites this paper
• Evaluating the benefit of adjuvant radiotherapy after extensive lymph node dissection for gastric cancer: a single-institute retrospective study

  2021cites this paper
• Assessment of the value of adjuvant radiotherapy for treatment of gastric adenocarcinoma based on pattern of post-surgical progression

  2021cites this paper
• Beyond the Guidelines: The Grey Zones of the Management of Gastric Cancer. Consensus Statements from the Gastric Cancer Italian Network (GAIN)

  2021cites this paper
• Exocrine pancreatic insufficiency in long-term follow-up after curative gastric resection with D2 lymphadenectomy: A cross-sectional study.

  2021cites this paper
• Dosimetric Evaluation of 3-Dimensional Conformal Radiotherapy Technique in Postoperative Patients with Gastric Carcinoma: When Is IMRT Really Needed?

  2020cites this paper
• An Immune Cell Signature Is Associated With Disease-Free Survival and Adjuvant Chemosensitivity of Patients With Resectable Gastric Cancer

  2020cites this paper
• The Survival Benefit From the Addition of Radiation to Chemotherapy in Gastric Cancer Patients Following Surgical Resection.

  2020cites this paper
• A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial.

  2020cites this paper
• Concurrent versus sandwich treatment in adjuvant treatment in high risk operated gastric cancer: A single center experience.

  2020cites this paper
• [Gastric and pancreatic cancers: Will neoadjuvant (chemo)radiotherapy replace adjuvant chemoradiotherapy?]

  2020cites this paper
• Cancers gastriques et pancréatiques : la (chimio)radiothérapie néoadjuvante remplacera-t-elle la chimioradiothérapie adjuvante ?

  2020cites this paper
• Careful dose modification of apatinib as third or further-line treatment in advanced gastric cancer patients with poor performance status

  2019cites this paper
• Radiation Therapy for Gastric Cancer

  2019cites this paper
• ASAP1 promotes tumor progression and angiogenesis and independently predicts poor prognosis and lymph node metastasis of gastric cancer

  2019cites this paper
• Stage‐matched survival differences by ethnicity among gastric cancer patients of Asian ancestry treated in the United States

  2019cites this paper
• Adjuvant Radiochemotherapy versus Chemotherapy Alone for Gastric Cancer: Implications for Target Definition

  2019cites this paper
• Gastrointestinal System Cancers

  2019cites this paper
• S3-Leitlinie Magenkarzinom – Diagnostik und Therapie der Adenokarzinome des Magens und des ösophagogastralen Übergangs – Langversion 2.0 – August 2019. AWMF-Registernummer: 032/009OL

  2019cites this paper
• Predictive value of pancreatic dose-volume metrics on sarcopenia rate in gastric cancer patients treated with adjuvant chemoradiotherapy.

  2019cites this paper
• Prognostic factors for survival in patients with gastric cancer: Single-centre experience

  2019cites this paper
• The necessity of adjuvant radiotherapy for locally advanced gastric cancer in China

  2019cites this paper
• A 21-gene Support Vector Machine classifier and a 10-gene risk score system constructed for patients with gastric cancer

  2019cites this paper
• Current status of adjuvant chemotherapy for gastric cancer

  2019cites this paper
• ADJUVANT CHEMORADIOTHERAPY AFTER SUBTOTAL OR TOTAL GASTRECTOMY AND D2 LIMPHADENECTOMY INCREASES SURVIVAL IN ADVANCED GASTRIC CANCER?

  2019cites this paper
• Prognostic factors for survival in patients with gastric cancer: Single instution experience

  2019cites this paper
• Predictors of survival outcome following radical gastrectomy for gastric cancer

  2019cites this paper
• Gastric cancer: adjuvant chemotherapy versus chemoradiation. A clinical point of view.

  2019influential citation
• Postoperative Radiotherapy Improves Survival in Gastric Signet-Ring Cell Carcinoma: a SEER Database Analysis

  2019cites this paper
• Role of lymph node ratio in selection of adjuvant treatment (chemotherapy vs. chemoradiation) in patients with resected gastric cancer.

  2018cites this paper
• Predictors of overall survival after surgery in gastric cancer patients from a Latin-American country.

  2018cites this paper
• Optimal management of resected gastric cancer

  2018cites this paper
• Survival outcomes and patterns of failure after D2 dissection and adjuvant chemoradiotherapy for locally advanced gastric cancer: a retrospective study.

  2018cites this paper
• [Chemotherapy and chemoradiotherapy indications in the treatment of locally advanced gastric carcinoma].

  2018cites this paper
• Gastric Cancer (Siewert Type III)

  2018cites this paper
• Postoperative sequential chemotherapy and radiotherapy for locally advanced gastric cancer

  2018cites this paper
• Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial.

  2018cites this paper
• Lauren Histologic Type Is the Most Important Factor Associated With Pattern of Recurrence Following Resection of Gastric Adenocarcinoma

  2018cites this paper
• Comparison of perioperative chemotherapy with adjuvant chemoradiotherapy for resectable gastric cancer: findings from a population-based study.

  2018cites this paper
• Gastrointestinal Malignancies

  2018cites this paper
• Preoperative radiation therapy in the surgical management of gastric and junctional adenocarcinoma: Should lymph node retrieval guidelines be altered?

  2018cites this paper
• PROGNOSTIC BIOMARKERS IN GASTRIC CANCER

  2018cites this paper
• Radiation Therapy in Gastric Cancer

  2018cites this paper
• Dosimetric comparison of 3-dimensional conformal radiotherapy, volumetric modulated arc therapy, and helical tomotherapy for postoperative gastric cancer patients

  2017cites this paper
• Adjuvant Chemoradiotherapy for Non-Pretreated Gastric Cancer

  2017cites this paper
• Exploration of the Radiotherapeutic Clinical Target Volume Delineation for Gastric Cancer from Lymph Node Metastases.

  2017cites this paper
• Patterns of Care for Radiotherapy in the Neoadjuvant and Adjuvant Treatment of Gastric Cancer: A Twelve-Year Nationwide Cohort Study in Korea

  2017cites this paper
• Relationship between epithelial cell adhesion molecule (EpCAM) overexpression and gastric cancer patients: A systematic review and meta-analysis

  2017cites this paper
• Role of postoperative chemoradiotherapy in the therapeutic management of adenocarcinomas of the stomach and oesogastric junction

  2017cites this paper
• Adjuvant Chemoradiation for Localized Gastric Adenocarcinoma: AnInstitutional Experience

  2017influential citation
• Lymph Node Burden as a Predictive Factor for Selective Chemoradiotherapy in Patients With Locally Advanced Gastric Cancer After a D2 Dissection: A Retrospective Study

  2017cites this paper
• Irinotecan monotherapy as third-line treatment for advanced gastric cancer refractory to fluoropyrimidines, platinum, and taxanes

  2017cites this paper
• Radiotherapy in Gastric Cancer with Peritoneal Carcinomatosis

  2017cites this paper
• Outcomes of radiation therapy for resectable M0 gastric cancer

  2017cites this paper
• Multimodal Therapies for Upper Gastrointestinal Cancers – Past, Now, and Future

  2017cites this paper
• Recent insights in the therapeutic management of patients with gastric cancer.

  2016cites this paper
• Adjuvant radiochemotherapy for gastric cancer: Should we use prognostic factors to select patients?

  2016cites this paper
• Mise en garde

  2016cites this paper
• Testing and Multiple Testing Arbitrary Dependence

  2016cites this paper
• Advanced gastric cancer: What we know and what we still have to learn.

  2016cites this paper
• False discovery rate control for high dimensional networks of quantile associations conditioning on covariates

  2016cites this paper
• A retrospective study on intensity-modulated radiation therapy combined with chemotherapy after D2 radical surgery for gastric carcinoma.

  2016cites this paper
• [Role of postoperative chemoradiotherapy in the therapeutic management of adenocarcinomas of the stomach and oesogastric junction].

  2016cites this paper
• Current adjuvant treatment modalities for gastric cancer: From history to the future.

  2016cites this paper
• Postoperative chemoradiotherapy versus chemotherapy for R0 resected gastric cancer with D2 lymph node dissection: an up-to-date meta-analysis

  2016cites this paper
• Multimodale Therapie des lokalisierten Magenkarzinoms

  2016cites this paper
• Chapter 47 – Gastric/GE Junction Cancer

  2016cites this paper
• IKKε and TBK1 expression in gastric cancer

  2016cites this paper
• Prognostic Factors of Recurrence Pattern , Survival and Toxicity in Patients with Gastric Cancer Treated According to Protocol INT-0116 with 3 D-Conformal Radiotherapy

  2016cites this paper
• Clinical, Histological and Prognosis Correlations in Diagnosis and Treatment of Gastric Cancer

  2016cites this paper
• Postoperative chemoradiotherapy results in gastric cancer patients from the middle black sea region of Turkey

  2016influential citation
• Postoperative adjuvant treatment for gastric cancer improves long-term survival after curative resection and D2 lymphadenectomy. Results from a Latin American Center.

  2016cites this paper
• Gastroesophageal Cancer: Prognostic Factors and Treatment Results

  2016cites this paper
• Quelle place pour la chimioradiothérapie postopératoire dans la prise en charge thérapeutique des adénocarcinomes de l’estomac et de la jonction œsogastrique ?

  2016cites this paper
• Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes

  2015cites this paper
• Effect of adjuvant chemoradiotherapy on survival of gastric cancer patients: single center experience from the southeast region of Turkey.

  2015influential citation
• Gastric cancer recurrence after resection and adjuvant chemoradiation

  2015cites this paper
• Effects of adjuvant radiotherapy on completely resected gastric cancer: A radiation oncologist's view of the ARTIST randomized phase III trial.

  2015cites this paper
• Emerging issues in multimodality treatment of gastric cancer

  2015cites this paper
• Adjuvant and/or neoadjuvant therapy for gastric cancer? A perspective review

  2015cites this paper
• Adjuvant therapy for gastric cancer: what have we learned since INT0116?

  2015cites this paper
• β-elemene enhances the radiosensitivity of gastric cancer cells by inhibiting Pak1 activation.

  2015cites this paper
• Clinical outcome and toxicity of 3D-conformal radiotherapy combined with chemotherapy based on the Intergroup SWOG 9008/INT0116 study protocol for gastric cancer.

  2015cites this paper
• Computed tomography-guided percutaneous microwave ablation therapy for lung cancer.

  2015cites this paper
• Radiation Treatment for Gastric Cancer

  2015cites this paper
• Phase I study of postoperative radiotherapy concurrent with S-1 in patients with gastric cancer

  2015cites this paper
• Survival in gastric cancer in relation to postoperative adjuvant therapy and determinants.

  2015cites this paper
• Adjuvant Chemoradiotherapy in Gastric Cancer: A Pooled Analysis of the AIRO Gastrointestinal Group Experience

  2015influential citation
• A phase II trial of concurrent 3D-CRT/IMRT and oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX) in gastric cancer patients with R0 gastrectomy and D2 lymph node dissection

  2015cites this paper